Interstitial fibrosis in hypercholesterolemic rats: Role of oxidation, matrix synthesis, and proteolytic cascades

Kidney International

Volumn 53, Issue 5, 1998, Pages 1182-1189

  Eddy, Allison A ^a,b   Liu, Elaine ^a   Mcculloch, Lori ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

Author keywords

Antioxidants; Oxidized low density lipoproteins; Renal fibrosis; Tissue inhibitor of metalloproteinases; Urokinase type plasminogen activator

Indexed keywords

COLLAGEN TYPE 4; MESSENGER RNA; PROCOLLAGEN; TISSUE INHIBITOR OF METALLOPROTEINASE; UROKINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROGENESIS; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HYPERCHOLESTEROLEMIA; KIDNEY FIBROSIS; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; RAT; RNA ANALYSIS; UNINEPHRECTOMY;

EID: 0031869430     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1998.00889.x     Document Type: Article

References (56)

1. EDDY AA: Molecular insights into renal interstitial fibrosis. J Am Soc Nephrol 7:2495-2508, 1996
2. DIAMOND JR: Effect of lipid abnormalities on the progression of renal damage. Analogous pathobiologic mechanisms in glomerulosclerosis and atherosclerosis. Kidney Int 39(Suppl 31):S29-S34, 1991
3. MOORHEAD JF, CHAN MK, EL-NAHAS M, VARGHESE Z: Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease. Lancet 2:1309-1311, 1982
4. WELLMANN KF, VOLK BW: Renal changes in experimental hypercholesterolemia in normal and in subdiabetic rabbits. II. Long-term studies. Lab Invest 24:144-155, 1971
5. PERIC-GOLIA L, PERIC-GOLIA M: Aortic and renal lesions in hyper-cholesterolemic adult, male, virgin Sprague-Dawley rats. Atherosclerosis 46:57-65, 1983
6. KASISKE BL, O'DONNELL MP, CLEARY MP, KEANE WF, PHILLIPS F: Effects of reduced renal mass on tissue lipids and renal injury in hyperlipidemic rats. Kidney Int 35:40-47, 1989
7. KASISKE BL, O'DONNELL MP, SCHMITZ PG, KIM Y, KEANE WF: Renal injury of diet-induced hypercholesterolemia in rats. Kidney Int 37:880-891, 1990
8. MAGIL AB: Tubulointerstitial lesions in young Zucker rats. Am J Kidney Dis 25:478-485, 1995
9. HOHBACH J, GRÖNE EF, GWINNER W, OLBRICHT C. GRÖNE H-J: Hyperlipidaemia aggravates tubulointerstitial damage in anti-Thyl glomerulonephritis. (abstract) J Am Soc Nephrol 7:1855, 1996
10. EDDY AA: Interstitial inflammation and fibrosis in rats with diet-induced hypercholesterolemia. Kidney Int 50:1139-1149, 1996
11. FREEMAN M, ASHKENAS J, REES DJG, KINGSLEY DM, COPELAND NG, JENKINS NA, KRIEGER M: An ancient, highly conserved family of cysteine-rich protein domains revealed by cloning type I and type II murine macrophage scavenger receptors. Proc Natl Acad Sci USA 87:8810-8814, 1990
12. OTTNAD E, PARTHASARATHY S, SAMBRANO GR, RAMPRASAD MP, QUEHENBERGER O, KONDRATENKO N, GREEN S, STFINBERG D: A macrophage receptor for oxidized low density lipoprotein distinct from the receptor for acetyl low density lipoprotein: Partial purification and role in recognition of oxidatively damaged cells. Proc Natl Acad Sci USA 92:1391-1395, 1995
13. ENDEMANN G, STANTON LW, MADDEN KS, BRYANT CM, WHITE RT, PROTTER AA: CD36 is a receptor for oxidized low density lipoprotein. J Biol Chem 268:11811-11816, 1993
14. STANTON LW, WHITE RT, BRYANT CM, PROTTER AA, ENDEMANN G: A macrophage Fc receptor for IgG is also a receptor for oxidized low density lipoprotein, J Biol Chem 267:22446-22451, 1992
15. HOLNESS CL, DA SILVA RP, FAWCELL J, GORDON S, SIMMONS DL: Macrosialin, a mouse macrophage-restricted glycoprotein, is a member of the lamp/Igp family. J Biol Chem 268:9661-9666, 1993
16. ELOMAA O, KANGAS M, SAHLBERG C, TUUKKANEN J, SORMUNEN R, LIAKKA A, THESLEFE I, KRAAL G, TRYGGVASON K: Cloning of a novel bacteria-binding receptor structurally related to scavenger receptors and expressed in a subset of macrophages. Cell 80:603-609, 1995
17. RAMPRASAD MP, FISCHER W, WITZTUM JL, SAMBRANO GR, QUEHENBERGER O, STEINBERG D: The 94- to 97-kDa mouse macrophage membrane protein that recognizes oxidized low density lipoprotein and phosphatidylserine-rich liposomes is identical to macrosialin, the mouse homologue of human CD68. Proc Natl Acad Sci USA 92:9580-9584, 1995
18. ACTON S, RIGOTTI A, LANDSCHULZ KT, HOBBS HH, KRIEGER M: Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 271:518-520, 1996
19. ONG ACM, MOORHEAD JF: Tubular lipidosis: Epiphenomenon or pathogenetic lesion in human renal disease? Kidney Int 45:753-762, 1994
20. BIRKEDAL-HANSEN H, MOORE WGI, BODDEN MK, WINDSOR LJ, BIRKEDAL-HANSEN B, DE CARLO A, ENGLER JA: Matrix metalloproteinases: A review. Crit Rev Oral Biol Med 4:197-250, 1993
21. VASSALLI J-D, SAPPINO A-P, BELIN D: The plasminogen activator/ plasmin system. J Clin Invest 88:1067-1072, 1991
22. DRUKKER A, EDDY AA: Failure of antioxidant therapy to attenuate interstitial disease in rats with reversible nephrotic syndrome. J Am Soc Nephrol (in press)
23. EDDY AA, MICHAEL AF: Acute tubulointerstitial nephritis associated wtih aminonucleoside nephrosis. Kidney Int 33:14-23, 1988
24. CATIGNANI GL, BIERI JG: Simultaneous determination of retinol and alpha-tocopherol in serum or plasma by liquid chromatography. Clin Chem 29:708-712, 1983
25. EDDY AA: Protein restriction reduces transforming growth factor-β and interstitial fibrosis in nephrotic syndrome. Am J Physiol 266:F884-F893, 1994
26. KIVIRIKKO KI, LAITINEN O, PROCKOP DJ: Modifications of a specific assay for hydroxyproline in urine. Analyt Biochem 19:249-255, 1967
27. OHKAWA H, OHISHI N, YAGI K: Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analyt Biochem 95:351-358, 1979
28. JONES CL, BUCH S, POST M, MCCULLOCH L, LIU E, EDDY AA: The pathogenesis of interstitial fibrosis in chronic purine aminonucleoside nephrosis. Kidney Int 40:1020-1031, 1991
29. CHIRGWIN JM, PRZYBYLA AE, MACDONALD RJ, RUTTER WJ: Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294-5299, 1979
30. TOMAN PD, DE CROMBRUGGHE B: The mouse type-III procollagenencoding gene: Genomic cloning and complete DNA sequence. Gene 147:161-168, 1994
31. MENOUD P-A, SAPPINO N, BOUDAL-KHOSHBEEN M, VASSALLI J-D, SAPPINO A-P: The kidney is a major site of α2-antiplasmin production. J Clin Invest 97:2478-2484, 1996
32. TRACHTMAN H, SCHWOB N, MAESAKA J, VALDERRAMA E: Dietary vitamin E supplementation ameliorates renal injury in chronic puromycin aminonucleoside nephropathy. J Am Soc Nephrol 5:1811-1819, 1995
33. LEE HS, JEONG JY, KIM BC, KIM YS, ZHANG YZ, CHUNG HK: Dietary antioxidant inhibits lipoprotein oxidation and renal injury in experimental focal segmental glomerulosclerosis. Kidney Int 51:1151-1159, 1997
34. HIRANO T, MOROHOSHI T: Treatment of hyperlipidemia with probucol suppresses the development of focal and segmental glomerulosclerosis in chronic aminonucleoside nephrosis. Nephron 60:443-447, 1992
35. MODI KS, SCHREINER GF, PURKERSON ML, KLAHR S: Effects of probucol in renal function and structure in rats with subtotal kidney ablation. J Lab Clin Med 120:310-317, 1992
36. WITZTUM JL: Drugs used in the treatment of hyperlipoproteinemias, in Goodman & Gilman's The Pharmacological Basis of Therapeutics (9th ed), edited by HARMAN JG, LIMBIRD LE, MOLINOFF PB, RUDDON RW, GILMAN AG, New York, McGraw-Hill, 1996, pp 875-897
37. REMUZZI G, RUGGENENTI P, BENIGNI A: Understanding the nature of renal disease progression. Kidney Int 51:2-15, 1997
38. SCHLONDORFF D: Cellular mechanisms of lipid injury in the glomerulus. Am J Kidney Dis 22:72-82, 1993
39. KEANE WF: Lipids and the kidney. Kidney Int 46:910-920, 1994
40. LEE HS, KIM BC, KIM YS, CHOI KH, CHUNG HK: Involvement of oxidation in LDL-induced collagen gene regulation in mesangial cells. Kidney Int 50:1582-1590, 1996
41. GALIS ZS, SUKHOVA GK, LARK MW, LIBBY P: Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 94:2493-2503, 1994
42. KRISTENSEN P, ERIKSEN J, DANO K: Localization of urokinase-type plasminogen activator messenger RNA in the normal mouse by in situ hybridization. J Histochem Cytochem 39:341-349, 1991
43. MOLL S, SCHIFFERLI JA, HUARTE J, LEMOINE R, VASSALLI J-D, SAPPINO A-P: LPS induces major changes in the extracellular proteolytic balance in the murine kidney. Kidney Int 45:500-508, 1994
44. TIPPING PG, DAVENPORT P, GALLICCHIO M, FILONZI EL, APOSTOLOPOULOS J, WOJTA J: Atheromatous plaque macrophages produce plasminogen activator inhibitor type-1 and stimulate its production by endothelial cells and vascular smooth muscle cells. Am J Pathol 143:875-885, 1993
45. FALCONE DJ, MCCAFFREY TA, HAIMOVITZ-FRIEDMAN A, VERGILIO J, NICHOLSON AC: Macrophage and foam cell release of matrix-bound growth factors. J Biol Chem 268:11951-11958, 1993
46. LUPU F, HEIM DA, BACHMANN F, HURNI M, KAKKAR VV, KRUITHOF KO: Plasminogen activator expression in human atherosclerotic lesions. Arterioscler Thromb Vasc Biol 15:1444-1455, 1995
47. RAJAVASHISTH TB, ANDALIBI A, TERRITO MC, BERLINER JA, NAVAB M, FOGELMAN AM, LUSIS AJ: Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins. Nature 344:254-257, 1990
48. DING G, VAN GOOR H, RICARDO SD, ORLOWSKI JM, DIAMOND JR: Oxidized LDL stimulates the expression of TGF-β and fibronectin in human glomerular epithelial cells. Kidney Int 51:147-154, 1997
49. SIMMONS-MENCHACA M, QIAN M, YU W, SANDERS BG, KLINE K: RRR-alpha-tocopheryl succinate inhibits DNA synthesis and enhances the production and secretion of biologically active transforming growth factor-beta by avian retrovirus-transformed lymphoid cells. Nutr Cancer 24:171-185, 1995
50. TURLEY JM, FUNAKOSHI S, RUSCETTI FW, KASPER J, MURPHY WJ, LONGO DL, BIRCHENALL-ROBERTS MC: Growth inhibition and apoptosis of RL human B lymphoma cells by vitamin E succinate and retinoic acid: Role for transforming growth factor beta. Cell Growth Differ 6:655-663, 1995
51. YAMAMOTO T, NOBLE NA, MILLER DE, BORDER WA: Sustained expression of TGF-β1 underlies development of progressive kidney fibrosis. Kidney Int 45:916-927, 1994
52. BASSING CH, YINGLING JM, HOWE DJ, WANG T, HE WW, GUSTAFSON ML, SHAH P, DONAHOE PK, WANG, X-F: A transforming growth factor β type 1 receptor that signals to activate gene expression. Science 263:87-89, 1994
53. DAVIES M, MARTIN J, THOMAS GJ, LOVETT DH: Proteinases and glomerular matrix turnover. Kidney Int 41:671-678, 1992
54. WERB Z: Proteinases and matrix degradation, in Textbook of Rheumatology (3rd ed), edited by KELLY WN, HARRIS ED JR. RUDDY S, SLEDGE CB, Philadelphia, WB Saunders, 1989, pp 300-321
55. LACRAZ S, NICOD LP, CHICHEPORTICHE R, WELGUS H, DAYER J-M: IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes. J Clin Invest 96:2304-2310, 1995
56. MANCHANDA N, SCHWARTZ BS: Lipopolysaccharide-induced modulation of human monocyte urokinase production and activity. J Immunol 145:4174-4180, 1990